Last reviewed · How we verify
NCT05574725
Diagnostic Value of Smartphone Video in Epileptic Seizures
trial testing Smartphone in Value of Smartphone in Epilepsy in 84 participants. Status unknown.
20 October 2022
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 84 |
| Start date | 20 October 2022 |
| Primary completion | 20 October 2022 |
| Estimated completion | 20 October 2023 |
Drugs / interventions tested
- Smartphone
Conditions studied
- Value of Smartphone in Epilepsy — all drugs for Value of Smartphone in Epilepsy →
Sponsor
Assiut University
Who can join
Eligibility, any sex, with Value of Smartphone in Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. Accuracy of seizure diagnosis based on smartphone seizure semiology anaysis 2. Assess the factors that affect the diagnostic reliability of smartphone videos
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05574725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Smartphone
Trials testing the same drug.
- NCT05336188 — Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder · Phase 2 · recruiting
- NCT04464304 — Virtual Reality for Postoperative Pain Management · NA · completed
- NCT05109767 — The Effect of Virtual Reality Glass and Smartphone Game Application on Preoperative Anxiety in Children · NA · completed
- NCT03883659 — Smartphone-based Mobility Assessment and Individualized Exercise Programs for Patients With Frozen Shoulder · NA · completed
- NCT03745469 — The Effect of Smartphone Use Duration in Patients With Chronic Mechanical Neck Pain. · completed
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05574725 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 10 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05574725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing